 | Professor of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Director, Stroke Program, Northwestern Memorial Hospital, Chicago, Illinois
Disclosure: Mark J. Alberts, MD, has disclosed the following relevant financial relationships:
Received honoraria from: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; diaDexus, Inc.; EKR Therapeutics Inc.; Genentech, Inc.; Medscape LLC; Pfizer Inc.; sanofi-aventis; Schering-Plough Corporation; The Medicines Company
Received grants for clinical research from: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EKR Therapeutics Inc.; Genentech, Inc.; PhotoThera; sanofi-aventis; Schering-Plough Corporation
Served as an advisor or consultant for: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EKR Therapeutics Inc.; Genentech, Inc.; Pfizer Inc.; sanofi-aventis; Takeda Pharmaceuticals North America, Inc.; The Medicines Company
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; diaDexus, Inc.; EKR Therapeutics Inc.; Genentech, Inc.; Medscape LLC; sanofi-aventis; The Medicines Company |
What Are the Implications of ACST-2 for Patients With Asymptomatic Carotid Stenosis?
Atherosclerotic Disease of the Carotid Artery
Carotid Endarterectomy
Carotid Artery Stenting
COMMENTARY
CREST Results: Carotid Endarterectomy vs Stenting
Mark J. Alberts, MD
DisclosuresMarch 10, 2010
Citation: Brott TG. The Randomized Carotid Revascularization Endarterectomy vs Stenting Trial (CREST): primary results. Program and abstracts of the 2010 International Stroke Conference; February 23-26, 2010; San Antonio, Texas. Presentation 197.
Medscape Neurology © 2010 WebMD, LLC
Cite this: Mark J. Alberts. CREST Results: Carotid Endarterectomy vs Stenting - Medscape - Mar 10, 2010.
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
Mark J. Alberts, MD
Professor of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Director, Stroke Program, Northwestern Memorial Hospital, Chicago, Illinois
Disclosure: Mark J. Alberts, MD, has disclosed the following relevant financial relationships:
Received honoraria from: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; diaDexus, Inc.; EKR Therapeutics Inc.; Genentech, Inc.; Medscape LLC; Pfizer Inc.; sanofi-aventis; Schering-Plough Corporation; The Medicines Company
Received grants for clinical research from: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EKR Therapeutics Inc.; Genentech, Inc.; PhotoThera; sanofi-aventis; Schering-Plough Corporation
Served as an advisor or consultant for: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EKR Therapeutics Inc.; Genentech, Inc.; Pfizer Inc.; sanofi-aventis; Takeda Pharmaceuticals North America, Inc.; The Medicines Company
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; diaDexus, Inc.; EKR Therapeutics Inc.; Genentech, Inc.; Medscape LLC; sanofi-aventis; The Medicines Company